PP01 Clinical Issues in Type 1 and Type 2 Diabetes

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Diabetes & Glucose Metabolism-Clinical/Translational
Thursday, March 5, 2015: 11:15 AM-11:30 AM
Room 6A (San Diego Convention Center)
**This session is NOT eligible for CME credit**

Chairs:
Janet B McGill, MD, Washington Univ in St. Louis, Saint Louis, MO and Elliot J Rayfield, MD, Mount Sinai School of Medicine, New York, NY

Disclosures:
JBM: Advisory Group Member, Abbott Laboratories, Advisory Group Member, Astra Zeneca, Advisory Group Member, Aventis Pharmaceuticals, Investigator, Dexcom, Speaker, Jansen Pharmaceuticals, Advisory Group Member, Merck & Co., Investigator, Novartis Pharmaceuticals, Advisory Group Member, Novo Nordisk, Investigator, Pfizer Global R&D, Advisory Group Member, Sanofi, Consultant, Mannkind, Advisory Group Member, Eli Lilly & Company, Consultant, Boehringer-Ingelheim, Advisory Group Member, Abbvie. Nothing to Disclose: EJR Disclosure Not Provided: JLL
Eric G. Vajda, Ph.D., Preclinical Research and Develop, Ligand Pharmaceuticals Inc, La Jolla, CA, Diane J. Plotkin, Ph.D., Diane Plotkin Clinical Development Consultation Services, Poway, CA, Douglas K. Logan, M.D., Medpace Clinical Pharmacology Unit, Medpace, Inc., Cincinatti, OH, Yong-Xi Li, Ph.D., Medpace Bioanalytical Labs, Medpace, Inc., Cincinatti, OH, David G Orloff, M.D., Medical and Regulatory Affairs, Medpace, Inc., Cincinnati, OH, J. D. Pipkin, Ph.D., New Product Development, Ligand Pharmaceuticals Incorporated, San Diego, CA, Lin Zhi, Ph.D., Chemistry and Pharm Sciences, Ligand Pharmaceuticals Incorporated, La Jolla, CA and Keith B. Marschke, Ph.D., Ligand Pharmaceuticals Incorporated, La Jolla, CA
Poster Board Number: THR-669
Cecilia C. Low Wang, MD, Medicine / Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, Rebecca Sanagorski, NP, Endocrine Section, Denver VA Medical Center, Denver, CO, R Matthew Hawkins, PA-C, Medicine/Endocrinology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, Joanna Gibbs, PA-C, Medicine/Endocrinology, Univ of Colorado AMC School of Medicine, Aurora, CO, Kenneth Tompkins, MD, Medicine, Univ of Colorado AMC School of Medicine, Mark Bridenstine, MD, Medicine/Endocrinology, Univ Colorado AMC School of Medicine, Aurora, CO, Stacey Seggelke, CNS, BC-ADM, Medicine/Endocrinology, Univ Colorado AMC School of Medicine and Boris Draznin, MD, PhD, Medicine, University of Colorado School of Medicine, Aurora, CO
Poster Board Number: THR-662
Robert C Hood, MD, FRCPC, FACE1, Richard F Arakaki, MD2, Carol H Wysham, MD3, Ying Grace Li4, Julie A Settles5 and Jeffrey A Jackson5, (1)Endocrine Clinic of Southeast Texas, Beaumont, TX
(2)University of Hawaii at Manoa, Honolulu, HI
(3)Rockwood Center for Diabetes and Endocrinology, Spokane, WA
(4)Eli Lilly and Company, Indianapolis, IN
(5)Lilly USA, LLC, Indianapolis, IN
Poster Board Number: THR-658
Michael Grimes, MD1, Peter L Perreiah, MS1, Laura Potoski, PharmD2, Denise Plis, B.A.B.A.3 and R Harsha Rao, MD, FRCP1, (1)Division of Endocrinology, VA Pittsburgh Healthcare System, Pittsburgh, PA
(2)Pharmacy Service Line, VA Pittsburgh Healthcare System, Pittsburgh, PA
(3)Information Resources- VISN4, VA Healthcare Network, Wilkes-Barre, PA
Poster Board Number: THR-657